Skip to content
healthcare.dev

Members Mark Triple Antibiotic

NDC 68196-400, bacitracin zinc, neomycin, polymyxin B, ointment, from Sam's West Inc.

Product NDC
68196-400
Status
Listed
Labeler
Sam's West Inc
Dosage form
OINTMENT
Route
TOPICAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M004
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68196-400 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BACITRACIN ZINC400 [USP'U]/g
  • NEOMYCIN SULFATE3.5 mg/g
  • POLYMYXIN B SULFATE5000 [USP'U]/g

Pharmacologic classes

Aminoglycoside Antibacterial [EPC]; Aminoglycosides [CS]; Decreased Cell Wall Synthesis & Repair [PE]; Polymyxin-class Antibacterial [EPC]; Polymyxins [CS]

Package NDCNDC-11Package
68196-400-21681960400213 TUBE in 1 CARTON (68196-400-21) / 28 g in 1 TUBE (68196-400-64)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 68196-400 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68196-400 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68196-400. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.